Today: 11 June 2026
Exxon stock price in focus after Q4 beat: buyback, dividend and Golden Pass LNG loom
31 January 2026
2 mins read

Exxon stock price in focus after Q4 beat: buyback, dividend and Golden Pass LNG loom

New York, January 31, 2026, 10:22 EST — The market has closed.

  • Exxon Mobil shares ended the session at $141.40, rising 0.7%.
  • Q4 adjusted EPS hit $1.71, beating LSEG’s consensus estimate.
  • Investors are focused on a $20 billion buyback program stretching through 2026 and a March deadline for the first LNG shipment at Golden Pass.

Exxon Mobil’s shares (XOM) ended Friday at $141.40, climbing 0.7%. The oil giant revealed its Q4 earnings and unveiled plans for its next shareholder payout.

U.S. markets are closed for the weekend, so the real question is if investors will see the update as “good enough” after shares have climbed steadily over the past year. Oil prices and downstream margins have carried much of the weight for the sector, while chemicals remain the laggard. Reuters

Exxon’s results come amid efforts to convert major projects into steady cash flow, even as management faces a barrage of questions on geopolitical issues—from Venezuela to Guyana—that could swiftly shift risk dynamics.

Exxon disclosed in its 8-K filing that fourth-quarter 2025 earnings hit $6.5 billion, translating to $1.53 per share. Stripping out identified items, earnings rose to $7.3 billion, or $1.71 per share, the report revealed.

Exxon reported $12.7 billion in cash flow from operating activities, with free cash flow—what’s left after capital expenditures—coming in at $5.6 billion. The company returned $9.5 billion to shareholders, split between $4.4 billion in dividends and $5.1 billion spent on share buybacks.

Exxon highlighted output growth both on the call and in its prepared remarks. Adjusted earnings came in at $1.71 per share, surpassing the $1.68 consensus estimate from analyst data compiled by LSEG. The company also reported annual upstream production of 4.7 million barrels of oil equivalent per day — its highest level in over 40 years, it said.

Capital returns remain in focus. Exxon announced plans to buy back $20 billion of shares by 2026, contingent on “reasonable market conditions.” It also declared a first-quarter dividend of $1.03 per share, payable March 10 to those on record Feb. 12. The company reaffirmed its 2026 cash capital spending target of $27 billion to $29 billion. Exxon Mobil Corporation

Operating details showed a mixed bag. Reuters noted that adjusted downstream profit jumped 60% year-on-year to $2.9 billion in the quarter. But the chemicals segment swung to an adjusted loss of $11 million. RBC Capital Markets’ Biraj Borkhataria flagged this as the first negative chemicals result since Q4 2019, highlighting “the severity” of the industry downturn. Reuters

Project timing remains a key factor. Exxon CEO Darren Woods informed analysts that the Golden Pass LNG export terminal in Texas is set to deliver its first liquefied natural gas by early March. The roughly $10 billion project, a joint effort with QatarEnergy, has encountered delays and cost overruns. It also switched its lead contractor following a bankruptcy linked to the job, Reuters reported.

Woods highlighted Exxon’s optionality in Venezuela but stopped short of promising a comeback. He noted the company’s technology could lower costs for producing Venezuela’s heavy crude and said Exxon is still open to sending a technical team, though a stable investment climate is crucial. Chevron CEO Mike Wirth echoed those views. Woods also mentioned parts of Exxon’s Stabroek block in Guyana remain under force majeure because of a border dispute.

Chevron shares ended the day 3.3% higher at $176.90, highlighting the ongoing debate over how major U.S. producers are managing buybacks alongside spending and production growth.

The setup isn’t all one-directional. A dip in crude prices or refining margins would quickly drain cash flow, while a downturn in chemicals could drag on. Golden Pass has already faced delays, and new political or legal issues involving Venezuela and Guyana might push schedules further.

Trading picks up again Monday, with investors focused on further analyst updates regarding guidance and capital returns. Key upcoming dates include Feb. 12, the dividend record day, and early March, when Woods aims to deliver the first LNG at Golden Pass.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

S&P 500, Nasdaq, Dow edge higher as chip names catch a bid

S&P 500, Nasdaq, Dow edge higher as chip names catch a bid

11 June 2026
Oracle plunged 12.5% after projecting fiscal 2027 capital spending far above Wall Street estimates and planning to raise nearly $40 billion in debt and equity, dragging software stocks lower even as chipmakers fueled a partial tech rebound following Wednesday’s AI-led selloff, Reuters reported.
Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
First U.S. bank failure of 2026: What happened after Metropolitan Capital Bank & Trust was shut
Previous Story

First U.S. bank failure of 2026: What happened after Metropolitan Capital Bank & Trust was shut

Gold price set for a bumpy week after historic slide from record highs
Next Story

Gold price set for a bumpy week after historic slide from record highs

Go toTop